Nonalcoholic Steatohepatitis With Liver Fibrosis
1 clinical trials · Condition
◉ Watch Nonalcoholic Steatohepatitis With Liver Fibrosis
| Record | Firm | Date |
|---|---|---|
| Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) (NCT04321031) | Pfizer | 2020-06-15 |
Track Nonalcoholic Steatohepatitis With Liver Fibrosis automatically
Every clearance here is in the API, with alerts when new ones post.